Helix BioMedix, Inc. (HXBM)
OTCMKTS · Delayed Price · Currency is USD
3.290
-1.113 (-25.28%)
At close: Oct 2, 2026
Helix BioMedix Market Cap
Helix BioMedix has a market cap or net worth of $739.29 thousand as of November 10, 2026. It is the 49,900th most valuable company in the world and the 6,783rd biggest in the United States. Its market cap has decreased by 6.00% in one year.
Market Cap
739.29K
Enterprise Value
n/a
Revenue
2.07M
Global Rank
Country Rank
#6,783 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since July 26, 1995, Helix BioMedix's market cap has decreased from 1.59M to 739.29K, a decrease of -53.64%. That is a compound annual growth rate of -2.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 739.29K | 64.50% |
| Dec 31, 2025 | 449.42K | -75.00% |
| Dec 26, 2024 | 1.80M | -76.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Halberd | 1.27M |
| AXIM Biotechnologies | 1.17M |
| International Stem Cell | 1.16M |
| Protagenic Therapeutics | 977.51K |
| Evofem Biosciences | 834.94K |
| SQZ Biotechnologies Company | 707.79K |
| Aditxt | 698.58K |
| Mosaic ImmunoEngineering | 573.58K |